Why the study?
What are the temporal trends in vascular risk factor treatment and control rates among myocardial infarction survivors in the US from 1999 to 2012?
What are the temporal trends in vascular risk factor treatment and control rates among myocardial infarction survivors in the US from 1999 to 2012?
While cholesterol treatment has improved among MI survivors, blood pressure control and aspirin use remain suboptimal, representing missed opportunities for secondary prevention.
No takes yet. Share an insight, caveat, or question.
Persistent aspirin and BP gaps in MI survivors warrant attention; leaves open targeted secondary prevention research.
Shah et al. (2015) studied this question.